Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 3301 to 3315 of 7691 results

  1. NICE impact diagnostic pathology

    Find out more about the progress made in implementing NICE guidance on diagnostic pathology

  2. Privacy notice

    How we collect and use your personal information, and your rights under data protection legislation

  3. Diabetes: blood pressure (without moderate or severe frailty)

    This indicator has been updated and replaced by NICE indicator 249.

  4. Atrial fibrillation: pulse rhythm assessment in people at risk

    This indicator has been withdrawn following National Screening Committee recommendations and ongoing research.

  5. Weight management: BMI calculation in preceding 5 years

    This indicator has been withdrawn following discussions with the National Screening Committee.

  6. A new model for evaluating and purchasing antimicrobials in the UK

    Antimicrobial resistance (AMR) is an urgent global challenge. It causes around 700,000 deaths each year globally . That number is predicted to rise to

  7. Life sciences: how to get your product to market

    Support for industry to engage with NICE during all stages of health technology development

  8. Our projects and partners

    NICE research projects and partners.

  9. Resource impact of NICE guidance

    We estimate the costs or savings (budget impact) associated with technologies and guidelines so you can plan for and implement guidance.

  10. Resource planner

    Our tool to help you plan for and implement NICE guidance. View upcoming guidance and understand the impact of guidance on your resources.

  11. Medicines associated with dependence or withdrawal symptoms. Patient decision aid summary version on should I stop my benzodiazepine or z-drug?

    Should I stop my benzodiazepine or z-drug? Patient decision aid: summary Do not stop taking your benzodiazepine or z-drug suddenly What are...

  12. Diabetes: annual HbA1c (children) (IND49)

    This indicator covers the proportion of children and young people with diabetes who have had their glycated haemoglobin A1c (HbA1c) monitored in the previous 12 months. It measures outcomes that reflect the quality of care or processes linked by evidence to improved outcomes. This indicator was previously published as CCG67

  13. Health Technology Assessment Innovation Laboratory (HTA Lab)

    NICE's HTA Lab enables us to develop creative solutions to complex problems in health technology assessment.

  14. Medical technologies advisory committee

    Information, meeting dates and minutes of the medical technologies advisory committee

  15. NICE and health inequalities

    Our health inequalities guidance supports strategies that improve population health as a whole, while offering particular benefit to the most disadvantaged